This therapeutic effect was linked to the expansion and enhancement of effector and memory functions in tumor-infiltrating CD8+ T lymphocytes, along with a reduction in exhausted PD-1hi CTLA-4+ TIM-3+ CD8+ lymphocytes [68]. Here, CD8A is linked to neoplasm.